Form CORRESP - Correspondence:
SEC Accession No. 0001683168-24-002261
Filing Date
2024-04-10
Accepted
2024-04-10 11:11:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 18881
  Complete submission text file 0001683168-24-002261.txt   20145
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)